Charles Abrams, MD, is currently a Professor of Medicine at the University of Pennsylvania, where he is the Associate Chief of the Hematology-Oncology Division. Dr. Abrams graduated from Johns Hopkins University and Yale University School of Medicine, and was elected to Phi Beta Kappa and Alpha Omega Alpha. After an internship at Temple University Hospital, Dr. Abrams completed a residency and Hematology-Oncology fellowship at the University of Pennsylvania Hospital.

Dr. Abrams’ research is focused on phospholipid adaptor proteins and phospholipid kinases in the cytoskeletal dynamics of blood cells. Making extensive use of mouse genetics, his laboratory has given insight into the signaling cascades that are essential for normal hemostasis, but can also be perturbed during the generation of arterial thrombi. He is the Principal Investigator of two R01 awards and a K12 mentored training grant in clinical hematology, as well as the Project Leader of an NIH-supported Program Project. Dr. Abrams serves on the editorial boards of several journals, which include Blood, Thrombosis Research, and Current Opinions in Hematology. He has been elected to membership in the American Society of Clinical Investigation and the Association of American Physicians.

Dr. Abrams is Chair of the Hematology Board of the American Board of Internal Medicine, and is a member of their Board of Directors. He was the recent Chair of the NIH Center for Scientific Review (CSR) Hemostasis & Thrombosis (HT) Study Section, and previously served as Chair of the Review Committee on Thrombosis for the National Organization of the American Heart Association. Dr. Abrams was the Scientific Co-Chair of the 47th Annual Meeting of the American Society of Hematology.

back to top